Sosnowski Robert Edward 4
4 · Cyclacel Pharmaceuticals, Inc. · Filed Dec 14, 2010
Insider Transaction Report
Form 4
Sosnowski Robert Edward
VP, Marketing & Sales
Transactions
- Award
Option
2010-12-10+40,000→ 40,000 totalExercise: $1.59Exp: 2020-12-10→ Common Stock (40,000 underlying)
Footnotes (2)
- [F1]These options are exercisable over a four-year period, with 1/48 of the options granted vesting on a monthly basis.
- [F2]These securities were issued as part of the Issuer's annual equity compensation to executive officers.